Sinco Pharmaceuticals Holdings Limited (6833.HK)
HKD 0.17
(-12.23%)
HKD 0.17
(-12.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 353.7 Million | 75.08 Million | 305.71 Million | 137.3 Million | -9.54 Million | 255.89 Million |
| Net Income | 99.88 Million | 69.46 Million | 135.08 Million | 118.13 Million | 23.55 Million | -280.61 Million |
| Depreciation & Amortization | 16.31 Million | 11.35 Million | 6.67 Million | 9.39 Million | 10.33 Million | 10.36 Million |
| Deferred income taxes | - | - | - | - | 50.33 Million | 31.13 Million |
| Stock-based compensation | - | - | - | - | 19 Thousand | 540 Thousand |
| Change in working capital | 244.84 Million | -160.75 Million | 545.35 Million | -534.17 Million | -50.42 Million | -31.67 Million |
| Other non-cash items | 11.46 Million | 155.01 Million | -381.4 Million | 543.93 Million | -43.43 Million | 526.14 Million |
| Investing Cash Flow | -63.62 Million | -119.27 Million | -22.72 Million | -46.84 Million | -2.54 Million | -1.63 Million |
| Investments in PPE | -64.54 Million | -52.69 Million | -23.52 Million | -372 Thousand | -555 Thousand | -1.15 Million |
| Acquisitions | - | -68 Million | - | -1.99 Million | 1.99 Million | - |
| Investment purchases | -10 Million | -80 Million | -366.13 Million | -164 Million | -21.99 Million | - |
| Sales/Maturities of investments | 10 Million | 80 Million | 366.13 Million | 165.99 Million | 20 Million | - |
| Other Investing Activities | -34.07 Million | 1.42 Million | 795 Thousand | -46.47 Million | -1.99 Million | -476 Thousand |
| Financing Cash Flow | -189.72 Million | 35.04 Million | -97.1 Million | -169.87 Million | 156.44 Million | -249.59 Million |
| Debt repayment | -60.01 Million | -341.44 Million | -78.65 Million | -227.3 Million | -5.87 Million | -594.28 Million |
| Dividends payments | -18.11 Million | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 159.46 Million | 75.37 Million | - | - | - |
| Other Financing Activities | -213.22 Million | 217.02 Million | -93.82 Million | 57.42 Million | 162.31 Million | 344.68 Million |
| Accounts receivables | -195.89 Million | -133.87 Million | 364.06 Million | -547.62 Million | -5.85 Million | 9.81 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -19.87 Million | -26.87 Million | 181.29 Million | 13.45 Million | -44.56 Million | -41.48 Million |
| Other working capital | 51.41 Million | 128.56 Million | -127.34 Million | 140.44 Million | -126.08 Million | 202.71 Million |
| Cash at beginning of period | 329.14 Million | 326.05 Million | 143.76 Million | 224.75 Million | 80.34 Million | 75.65 Million |
| Cash at end of period | 437.92 Million | 329.14 Million | 326.05 Million | 143.76 Million | 224.75 Million | 80.34 Million |
| Capital Expenditure | -64.54 Million | -52.69 Million | -23.52 Million | -372 Thousand | -555 Thousand | -1.15 Million |
| Effect of forex changes on cash | 8.43 Million | 12.23 Million | -3.59 Million | -1.57 Million | 63 Thousand | 29 Thousand |
| Net cash flow / Change in cash | 108.77 Million | 3.09 Million | 182.28 Million | -80.99 Million | 144.41 Million | 4.69 Million |
| Free Cash Flow | 289.15 Million | 22.39 Million | 282.19 Million | 136.92 Million | -10.1 Million | 254.73 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 23.87 Million | 99.88 Million | 22.75 Million | 19.59 Million | 69.46 Million | 7.53 Million |
| Depreciation & Amortization | 10.11 Million | 16.31 Million | 9.01 Million | 7.3 Million | 11.35 Million | 6.44 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 244.84 Million | -282.32 Million | 117.96 Million | -160.75 Million | 89.24 Million |
| Other non-cash items | -301.98 Million | 11.46 Million | 178.46 Million | 280.91 Million | 155.01 Million | -115.85 Million |
| Investing Cash Flow | -21.47 Million | -63.62 Million | -15.99 Million | -47.62 Million | -119.27 Million | -29.22 Million |
| Investments in PPE | -15.58 Million | -64.54 Million | -12.98 Million | -16.56 Million | -52.69 Million | -30.02 Million |
| Acquisitions | - | - | - | - | -68 Million | - |
| Investment purchases | - | -10 Million | - | - | -80 Million | - |
| Sales/Maturities of investments | - | 10 Million | - | - | 80 Million | - |
| Other Investing Activities | -5.89 Million | -34.07 Million | -3.01 Million | -31.06 Million | 1.42 Million | 804 Thousand |
| Financing Cash Flow | 115.62 Million | -189.72 Million | -1.23 Million | -188.49 Million | 35.04 Million | -89.58 Million |
| Debt repayment | - | -60.01 Million | - | -18.75 Million | -341.44 Million | - |
| Dividends payments | - | -18.11 Million | - | -18.11 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | -6.06 Million |
| Common Stock Issuance | - | - | - | - | 159.46 Million | - |
| Other Financing Activities | 115.62 Million | -213.22 Million | -1.23 Million | -189.13 Million | 217.02 Million | -83.51 Million |
| Accounts receivables | - | -195.89 Million | -240.4 Million | 44.51 Million | -133.87 Million | -108.73 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | -19.87 Million | -98.55 Million | 78.67 Million | -26.87 Million | -42.9 Million |
| Other working capital | - | 51.41 Million | 56.63 Million | -5.22 Million | 128.56 Million | 240.88 Million |
| Cash at beginning of period | 437.92 Million | 329.14 Million | 520.82 Million | 329.14 Million | 326.05 Million | 456.7 Million |
| Cash at end of period | 282 Million | 437.92 Million | 437.92 Million | 520.82 Million | 329.14 Million | 329.14 Million |
| Capital Expenditure | -15.58 Million | -64.54 Million | -12.98 Million | -16.56 Million | -52.69 Million | -30.02 Million |
| Effect of forex changes on cash | 17.93 Million | 8.43 Million | 6.42 Million | 2.01 Million | 12.23 Million | 3.87 Million |
| Net cash flow / Change in cash | -155.91 Million | 108.77 Million | -82.9 Million | 191.67 Million | 3.09 Million | -127.56 Million |
| Free Cash Flow | -283.58 Million | 289.15 Million | -85.07 Million | 409.22 Million | 22.39 Million | -42.66 Million |
7635
690D
5530
600255
PLAY
XTEPY